Endometrial Cancer Trial, Recruiting NCT06669533 Sponsor: University of Alabama at Birmingham Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06669533
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a Type 3 transformation zone (a specific finding on cervical examination) confirmed before the start of the trial
  • People aged 25 years or older

Who may not be able to join:

  • People who have a Type 1 or Type 2 transformation zone (different cervical examination findings) before the trial begins
  • People who are currently pregnant
  • People who have previously had a hysterectomy (surgical removal of the uterus)
  • People who have any cancerous lesions
  • People who have active cervicitis (a current infection or inflammation of the cervix)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Warner K Huh, MD, University of Alabama at Birmingham

Phone: 2059341555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 February 2025
Est. completion
4 November 2026

Where this trial is recruiting

Cameroon

Primary endpoints

Conversion rate from Type 3 transformation zone (TZ) to Types 1 or 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov